Frontiers in Molecular Biosciences (Jun 2023)
Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers
- Chenxi Cao,
- Chenxi Cao,
- Chenxi Cao,
- Shuang Chen,
- Shuang Chen,
- Libo Wang,
- Zaoqu Liu,
- Zaoqu Liu,
- Zaoqu Liu,
- Xinwei Han,
- Xinwei Han,
- Xinwei Han
Affiliations
- Chenxi Cao
- Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Chenxi Cao
- Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Chenxi Cao
- Key Laboratory of Cardiac Injury and Repair of Henan Province, Zhengzhou, Henan, China
- Shuang Chen
- Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Shuang Chen
- Center of Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Libo Wang
- Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Zaoqu Liu
- Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Zaoqu Liu
- Interventional Institute of Zhengzhou University, Zhengzhou, Henan, China
- Zaoqu Liu
- Henan Interventional Therapy and Clinical Research Center, Zhengzhou, Henan, China
- Xinwei Han
- Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Xinwei Han
- Interventional Institute of Zhengzhou University, Zhengzhou, Henan, China
- Xinwei Han
- Henan Interventional Therapy and Clinical Research Center, Zhengzhou, Henan, China
- DOI
- https://doi.org/10.3389/fmolb.2023.1190116
- Journal volume & issue
-
Vol. 10
Abstract
No abstracts available.Keywords
